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Wnt signaling plays an important role in both oncogenesis and development. Activation of the Wnt pathway results in
stabilization of the transcriptional coactivator b-catenin. Recent studies have demonstrated that axin, which
coordinates b-catenin degradation, is itself degraded. Although the key molecules required for transducing a Wnt
signal have been identified, a quantitative understanding of this pathway has been lacking. We have developed a
mathematical model for the canonical Wnt pathway that describes the interactions among the core components: Wnt,
Frizzled, Dishevelled, GSK3b, APC, axin, b-catenin, and TCF. Using a system of differential equations, the model
incorporates the kinetics of protein–protein interactions, protein synthesis/degradation, and phosphorylation/
dephosphorylation. We initially defined a reference state of kinetic, thermodynamic, and flux data from experiments
using Xenopus extracts. Predictions based on the analysis of the reference state were used iteratively to develop a
more refined model from which we analyzed the effects of prolonged and transient Wnt stimulation on b-catenin and
axin turnover. We predict several unusual features of the Wnt pathway, some of which we tested experimentally. An
insight from our model, which we confirmed experimentally, is that the two scaffold proteins axin and APC promote
the formation of degradation complexes in very different ways. We can also explain the importance of axin
degradation in amplifying and sharpening the Wnt signal, and we show that the dependence of axin degradation on
APC is an essential part of an unappreciated regulatory loop that prevents the accumulation of b-catenin at decreased
APC concentrations. By applying control analysis to our mathematical model, we demonstrate the modular design,
sensitivity, and robustness of the Wnt pathway and derive an explicit expression for tumor suppression and
oncogenicity.
Introduction
Considerable effort employing biochemistry, genetics, and
pharmacology has been invested in identifying the web of
interactions that characterize signal transduction pathways in
metazoan organisms. Several conclusions can be drawn from
these efforts. Despite the large number of receptors, ligands,
and downstream targets, the number of signal transduction
pathways in metazoans is relatively small, arguably less than
20 (Gerhart 1999). This limited diversity occurs despite large
numbers of different organisms, cell types, states of growth,
and differentiation, as well as sexual dimorphism in biology.
Remarkably, these pathways are highly conserved, some
among all eukaryotes, most among all metazoans. Whereas
signaling pathways differ in detail, it is not clear whether
these differences are functionally signiﬁcant. Conservation in
the face of diversity of function raises the question of whether
the behaviors of the pathway are in reality as similar as they
seem when one compares more quantitative aspects of the
signals and responses, such as amplitude, duration, and ﬂux
(Heinrich et al. 2002). Finally, the structure and design of the
pathways are themselves a mystery. Is the structure of these
conserved pathways so deeply embedded in other conserved
process that it is difﬁcult to change any interaction, or does
conservation imply continuous selection for function (Ger-
hart and Kirschner 1997)?
Many of these questions require a more quantitative
understanding of the behavior of signaling pathways. Such
information is rarely available. Most mathematical models
have to be satisﬁed with a general conceptual understanding
and are seldom testable, as most parameters must be assumed
or inferred. It is partly for this reason that such theoretical
efforts up to now have had limited impact on experimen-
talists, who prefer powerful qualitative tools to construct
logical and formal models of pathway structures. Mathemat-
ical modeling is more advanced for metabolic networks,
where the pathways have been known for more than a half-
century and where more kinetic data have been available,
including more recent data on in vivo dynamics (Heinrich
and Schuster 1996). To develop a better quantitative under-
standing of a signal transduction pathway, we have recreated
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PLoS BIOLOGYa more accessible system for biochemical study. The Wnt
signaling pathway downstream of its immediate cytoplasmic
mediator, Dishevelled (Dsh), can be reconstituted in frog egg
extracts. The readout of the pathway is the rate of
degradation of the transcriptional coactivator, b-catenin.
We chose the Wnt pathway because it is active in the early
Xenopus embryo, it is widely used in many different contexts
in development, and it is also very important in human
cancer. Although the design features of the Wnt pathway are
highly conserved in evolution, it is not clear what purposes
those features serve. This paper is in part an answer to that
question.
The pivotal player in Wnt signaling is the scaffold protein
axin, which is required for the constitutive degradation of b-
catenin. Axin coordinates the assembly of a large complex
that includes the glycogen synthase kinase 3b (GSK3b);
another scaffold protein, adenomatous polyposis coli (APC);
and the negative regulators Dsh and GSK3b-binding protein
(glycogen synthase kinase-binding protein [GBP]/Frat). Bind-
ing of Wnt to its receptor, Frizzled, activates Dsh through an
as-yet-unknown process. In the absence of Wnt, GSK3b
bound to axin phosphorylates b-catenin bound to both axin
and APC. Phosphorylated b-catenin is a substrate for
ubiquitination and subsequent degradation through the F-
box protein b-TRCP, which is part of an SCF ubiquitin ligase
complex. In the presence of the Wnt signal, the activated Dsh
protein binds to axin and, through bound GBP, inhibits b-
catenin phosphorylation; this inhibits its ubiquitination and
consequent degradation. The buildup in b-catenin in the
presence of a Wnt signal leads to transcription of speciﬁc
genes.
Numerous questions arise from this general model. Why
are two scaffold proteins, APC and axin, both necessary? Do
their roles differ? Recently it has been discovered that axin,
like b-catenin, is an unstable protein (Yamamoto et al. 1999;
Tolwinski et al. 2003). In recent work (unpublished data), we
have further described the conditions under which axin is
unstable. We ask here what role axin instability plays in the
behavior of the Wnt pathway and in the responsiveness of the
pathway to the Wnt signal? Beyond these mechanistic
questions are important biological ones that lie beyond the
scope of this work but that may be raised by some of the
ﬁndings here. For example, mutations in APC seem to play a
particularly important role in colorectal cancer; is the
peculiar sensitivity to APC mutations in the colonic epithe-
lium understandable in terms of how the pathway performs
in that tissue? Similarly, GSK3b is also essential but not
commonly mutated in colorectal cancer; why is that the case?
No one has puriﬁed a discrete complex containing all the
major players in the Wnt pathway arrayed on the axin–APC
scaffolds, suggesting that the pathway might be affected by
nonproductive titration of components by subcomplexes. If
this is a problem, how is it avoided? The Wnt pathway is likely
present in all cell types, and yet several of its constituents are
used in other pathways; how is crosstalk or interference in
other pathways avoided? As we set out to produce a realistic
kinetic model of the Wnt pathway, we encountered other
questions. For example, quantitative measurements led to the
unusual ﬁnding that axin is present at very low concen-
trations. Is there a satisfactory explanation of this fact and of
other, previously unexplained, features of the pathway? We
are aware that some of the answers to speciﬁc questions could
lie in unknown components or unknown interactions among
known components. We were under no illusions that we
could accommodate all known interactions in a model at this
time or that we already knew all we need to know to construct
such a model. For this reason we have asked a more modest
question—whether the properties of the core pathway, as
presently understood, can provide insight into important
questions not yet answered or not yet clearly raised.
To answer such questions, we collected what we initially
thought were sufﬁcient quantitative data on rates, afﬁnities,
and ﬂuxes to derive a reference state model of the Wnt
pathway in this system. The provisional reference state model
reﬂected most of the known properties of the system, but
from this model we identiﬁed several rates and afﬁnity
constants whose values were critical to the behavior of the
model. We then went back and measured these. Thus this
paper contains a reference model, a large number of
experimental measurements needed to deﬁne this model,
theoretical predictions, and experimental tests of those
predictions, where possible. A general test of the validity of
the model is its predictive ability under a wide range of
conditions. From this analysis, several unexpected properties
emerged with signiﬁcance for understanding the biological
function of the Wnt pathway.
Results
A Proposed Kinetic Pathway
The model was based on the reaction scheme shown in
Figure 1. A few steps are labeled, such as the synthesis of axin
and b-catenin, the degradation of axin, the axin-independent
(basal) and axin-dependent degradation of b-catenin, as well
as the critical cycle involved in the phosphorylation of b-
catenin for degradation (Destruction Core Cycle). The output
is the formation of the b-catenin/T-cell factor (TCF) complex
and the input is the Wnt signal. Although many proteins
interact with the Wnt pathway, we have focused only on core
components known to be necessary for mediating a Wnt
signal in most contexts. These core proteins include GSK3b,
protein phosphatase 2A (PP2A), b-catenin, APC, axin, Dsh,
TCF, and Wnt. The reactions incorporated into our model
include protein synthesis/degradation, protein phosphoryla-
tion/dephosphorylation, and the assembly/disassembly of
protein complexes (Figure 1, solid arrows). Reactions medi-
ated by proteins that activate a process are represented with
broken arrows: (1) activation of Dsh by Wnt (step 1), (2)
activation of the release of GSK3b from APC/axin/GSK3b by
Dsh (step 3), and (3) activation of APC-dependent axin
degradation (step 15). The reactions and components in blue
are concerned with additional features of the pathway, as
discussed below.
The centerpiece of the model is the formation of the
unstable core complexes involved in b-catenin phosphoryla-
tion and subsequent destruction. In addition to b-catenin,
this set of complexes contains GSK3b and the scaffold
proteins APC and axin. The complexes assemble in several
steps: (1) binding of axin to APC (forward reaction of step 7);
(2) binding of GSK3b (forward reaction of step 6); (3)
phosphorylation of axin and APC by GSK3b (step 4).
Dephosphorylation of the core complex (step 5) is mediated
by PP2A. The ﬁrst step in b-catenin degradation is its binding
to APC*/axin*/GSK3b (step 8), after which it is phosphory-
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10). Our model assumes that the phosphorylation of b-
catenin by GSK3b is negligible in the absence of axin. Indeed,
recent work indicates that axin stimulates the phosphoryla-
tion of b-catenin by GSK3b at least 24,000-fold (Dajani et al.
2003). Free, phosphorylated b-catenin is rapidly polyubiqui-
tinated and degraded by the SCF complex and the protea-
some, respectively (step 11).
The dynamic properties of the model, such as the ﬂux
through the pathway, are also affected by binding of b-
catenin to other partners, such as TCF (step 16) and free APC
(step 17). In special cases (high axin concentrations), the ﬂux
through the system is affected by the binding of axin to
GSK3b (step 19) as well as b-catenin (step 18). We have
previously shown experimentally that TCF reduces the rate of
b-catenin degradation (Lee et al. 2001). Turnover of b-catenin
(steps 11, 12, and 13) and axin (steps 14 and 15) are included
in our model, but since biochemical experiments in Xenopus
egg extracts indicate that the turnover of GSK3b, Dsh, and
TCF is relatively slow (no detectable degradation after 3 h at
room temperature; unpublished data), the synthesis and
degradation of these proteins are not explicitly modeled.
The activation of the pathway in vivo, which results in the
stabilization of b-catenin, is initiated by binding of Wnt
ligands to Frizzled receptors and the subsequent transition of
Dsh from its inactive form (Dshi) to its active form (Dsha).
Since these events are still poorly deﬁned, both processes
have been combined in step 1. Interaction of Dsha with the
nonphosphorylated complex APC/axin/GSK3b (step 3) acti-
vates the release of GSK3b . This latter process requires the
activity of the GBP/Frat (not shown on our diagram).
Deactivation of Dsha occurs through an as-yet-unidentiﬁed
mechanism (step 2).
Analytical Description
The mathematical analysis is based on a series of balance
equations that describe the concentrations and complexes of
proteins in the Wnt pathway, as depicted in Figure 1. The set
of variables and the set of 15 differential equations we
obtained are given in Table S1, found at http://dx.doi.org/
10.1371/journal.pbio.0000010.st001, and Dataset S1, found at
http://dx.doi.org/10.1371/journal.pbio.000010.sd001, respec-
tively (Equations [A-1]–[A-15]). Stimulation of the pathway
by Wnt is described by a time-dependent function, Wnt(t).
Since Dsh, TCF, and GSK3b are degraded very slowly, we
assume that their concentrations remain constant through-
out the timecourse of a Wnt signaling event. The conserva-
tion equations for Dsh, TCF, and GSK3b are as follows:
Dsh0 ¼ Dshi þ Dsha ð1Þ
TCF0 ¼ TCF þ b-catenin=TCF ðÞ ð 2Þ
GSK3b
0 ¼ GSK3b þ APC=axin=GSK3b ðÞ
þ APC =axin =GSK3b
  
þ b-catenin=APC =axin =GSK3b
  
þ b-catenin =APC =axin =GSK3b
  
ð3Þ
Symbols with the superscript "0" denote total concentra-
tions.
Since the concentration of axin is very low (see below)
compared to the concentration of GSK3b, we replaced
Equation (3) with the simple relationship GSK3b
0 ¼ GSK3b.
Similarly, we omitted the concentration of complexes
containing axin in the conservation relationship for APC,
which leads to the following equation:
APC0 ¼ APC þ b-catenin=APC ðÞ : ð4Þ
Figure 1. Reaction Scheme for Wnt Signaling
The reaction steps of the Wnt pathway are numbered 1 to 19. Protein complexes are denoted by the names of their components, separated by a
slash and enclosed in brackets. Phosphorylated components are marked by an asterisk. Single-headed solid arrows characterize reactions taking
place only in the indicated direction. Double-headed arrows denote binding equilibria. Blue arrows mark reactions that have only been taken
into account when studying the effect of high axin concentrations. Broken arrows represent activation of Dsh by the Wnt ligand (step 1), Dsh-
mediated initiation of the release of GSK3b from the destruction complex (step 3), and APC-mediated degradation of axin (step 15). The broken
arrows indicate that the components mediate but do not participate stoichiometrically in the reaction scheme. The irreversible reactions 2, 4, 5,
9–11, and 13 are unimolecular, and reactions 6, 7, 8, 16, and 17 are reversible binding steps. The individual reactions and their role in the Wnt
pathway are explained in the text.
DOI: 10.1371/journal.pbio.0000010.g001
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axin-containing complexes for GSK3b and APC conservation
equations when we later consider the effect of large increases
in axin concentration.
The simplest possible equation was chosen to describe the
kinetics of each individual reaction. Synthesis of b-catenin
and axin are described by constant rates mi. Unimolecular
reactions are assumed to be irreversible and are described by
linear rate equations mi ¼ ki   Xj, where ki denotes the ﬁrst-
order rate constant and Xj denotes the concentration of the
reactants. Reversible binding steps (double-headed arrows in
Figure 1) are described by the equation mi¼kþiXjYl k i(Xj.Yl),
where Xj and Yl denote the concentrations of the binding
partners and (Xj.Yl) the concentration of their complex. The
Dsh-mediated release of GSK3b from the destruction com-
plex is described by an irreversible reaction that is
bimolecular in the concentrations of Dsh and the degrada-
tion complex. The model is simpliﬁed by assuming that the
reversible binding steps between axin, b-catenin, APC, and
TCF are very fast, such that the corresponding protein
complexes are in rapid equilibrium, so that only the
dissociation constants Ki ¼ k i/kþi are considered in the
kinetic description of these steps. The conservation equations
and the binding equilibria reduce the number of indepen-
dent dynamic variables. Accordingly, the original set of 15
differential equations is transformed into a set of only seven
ordinary differential equations coupled to four conservation
equations and four relationships for binding equilibria. For a
detailed mathematical description of the model and the
procedure for reducing the number of systems variables, see
Dataset S1.
Experimental Evaluation of the Reference and Stimulated
States
We deﬁne the reference state as the absence of Wnt
signaling (Wnt ¼ 0). In this unstimulated stationary state, Dsh
is inactive and does not affect the degradation complex. b-
Catenin concentration is kept low by continuous phosphor-
ylation and degradation. The reference state can be charac-
terized by the special values for its rate constants, its
equilibrium constants, and its conservation quantities. If
one can obtain values for all of these system parameters, the
model equations should allow for a straightforward calcu-
lation of the variables in the reference state. Currently, we
have experimental data for many of these parameters (see
below). For the remaining system parameters that were not
directly measured, we were able to derive numbers based on
experimental data of steady-state concentrations and ﬂuxes.
A number of parameters were set such that the results of the
model were in agreement with previous experimental data,
speciﬁcally with the experimentally determined rate of b-
catenin degradation (Salic et al. 2000; Lee et al. 2001). Finally,
a few parameters had to be estimated; the constraint used was
that the resulting model should be compatible with the
steady-state and ﬂux values. Table 1 lists the numeric values
of all of the input quantities of the model. These quantities
are either speciﬁc parameters, such as dissociation constants,
or systemic properties, such as steady-state concentrations or
ﬂuxes, from which the other parameters have been derived.
Both types of input quantities include experimental data as
well as estimated values. The speciﬁc numerical values affect
the model to differing degrees. In a later section, we analyze
the effects of changing the values of the parameters around
their reference numbers. The types of input data used for our
modeling can be divided into ﬁve groups.
The ﬁrst group of input data contains both total concen-
trations (Dsh
0, APC
0, TCF
0, and GSK3b
0) and steady-state
concentrations (Axin
0, b-catenin
0, b-catenin*). The total con-
centrations of Dsh, TCF, GSK3b, axin, b-catenin, and APC in
Xenopus egg extract were determined experimentally using
Western blot analysis by comparing the intensity of the signal
to that of known amounts of recombinant protein. The
concentration of phosphorylated b-catenin was estimated
because we have not been able to directly determine its level
in extracts. However, we estimate that this value is small
compared to that of nonphosphorylated b-catenin for the
following reasons: (1) Addition of axin to Xenopus extracts
dramatically increases the rate of b-catenin degradation.
Since the role of axin is to promote phosphorylation of b-
catenin, which is subsequently degraded, this would suggest
that normally a signiﬁcant pool of b-catenin exists in the
nonphosphorylated form. (2) Western blot analysis of Xenopus
extracts demonstrates that only a small percentage (,10%) of
total b-catenin can be detected as migrating with a slower
mobility, which likely represents the phosphorylated form of
b-catenin.
The second group of input data was experimentally
obtained from measurements of rates of dissociation of
protein complexes. Binding constants were calculated based
on the assumption that association rates approached that of
the diffusion limits for a typical protein in an aqueous
solution. The ratio K17/K8 ¼ 10 of the dissociation constants
characterizing the binding of b-catenin to APC and APC*/
axin*/GSK3b, respectively, is based on previous experimental
results demonstrating that b-catenin has a 10-fold lower
afﬁnity for nonphosphorylated compared to phosphorylated
APC (Salic et al. 2000). In addition, we have shown
experimentally (unpublished data; see Materials and Meth-
ods) that phosphorylated b-catenin dissociates from axin
more rapidly (reaction 10) than nonphosphorylated b-
catenin. Once phosphorylated, b-catenin will thus dissociate
from the axin complex and undergo polyubiquitination and
proteolysis.
The third group of input data consists of the two
concentration ratios in the Destruction Core Cycle for
complexes that either contain or lack b-catenin. The
concentration ratio for the complexes that lack b-catenin is
represented by the ratio of its phosphorylated versus
nonphosphorylated forms and reﬂects the relative activities
of its kinase(s) and phosphatase(s), respectively. By contrast,
the concentration ratio of the two b-catenin-containing
degradation complexes represents the relative activities of
b-catenin phosphorylation and the rate of release of
phosphorylated b-catenin from the complex. These parame-
ters were chosen rather arbitrarily to indicate roughly equal
kinase and phosphatase activities and yielded realistic values
for the overall ﬂuxes, given the known concentrations and
kinetic rate constants.
The fourth group of data includes the steady state ﬂux m11
for the degradation of b-catenin via the Wnt pathway and the
ﬂux ratio m13 / m11 describing the extent to which b-catenin is
degraded via non-Wnt mechanisms (e.g., via Siah-1 and
presenilin [Liu et al. 2001; Matsuzawa and Reed 2001; Kang
et al. 2002]). We have now measured this Wnt pathway–
PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 1 | Page 119
Mathematical Modeling of the Wnt Pathwayindependent degradation in Xenopus extracts (see Materials
and Methods; value shown in Table 1).
The ﬁnal group of input data consists of the characteristic
time constant (s) of selected processes. This is the time it
takes for the concentration to drop to 1/e of its initial value.
These characteristic times include sK.P ¼ 1/(k4 þ k5) for the
kinase/phosphatase cycle that mediates phosphorylation/
dephosphorylation of both APC and axin in the degradation
complex (steps 4 and 5), sGSK3b.ass¼1 / (k6 GSK3bþk 6) for the
binding equilibrium of GSK3b with the APC/axin complex
(step 6), and sax.deg for axin degradation (step 15). Values for
the rate of axin degradation were determined directly from
experiments performed in Xenopus egg extracts (unpublished
data). Experiments to determine the rate of APC and axin
dephosphorylation (sK.P ; 2.5 min) were performed using in
vitro
32P-labeled recombinant APC and axin. Radiolabeled
proteins were added to Xenopus egg extracts, and the loss of
radioactivity over time was assessed by SDS-PAGE and
autoradiography (Salic et al. 2000). The legend to Table 1
contains the values of rate constants calculated from the
input quantities using the described system of equations. The
values of all variables in the reference state are listed in the
ﬁrst column of Table 2. These values represent the steady
state solutions of system equations using the data in Table 1
as input quantities with the value of Wnt set at Wnt ¼ 0.
Using the reference state as a starting point, we consider
other stationary states that are attained when the pathway is
permanently stimulated. To describe the strength of Wnt
stimulation, we introduce a dimensionless quantity W ¼ Wnt/
Wnt
0 that represents the ratio of the Wnt concentration with
respect to its concentration Wnt
0 in a ‘‘standard’’ stimulated
(signaling) state. W ¼ 0 and W ¼ 1 characterize the reference
Table 1. Numeric Values of Input Quantities of the Model for the Reference State
Symbol Description Reference value
Concentrations
Dsh
0 total Dsh 100 nM
APC
0 total APC 100 nM
TCF
0 total TCF 15 nM
GSK
0 total GSK3b 50 nM
Axin
0 total axin 0.02 nM
b-catenin
0 total b-catenin 35 nM
b-catenin* free phosphorylated b-catenin 1n M
Dissociation constants
K6 binding of GSK3b to (APC/axin) 10 nM
K7 binding of APC to axin 50 nM
K8 binding of b-catenin to (APC/axin/GSK3b) 120 nM
K16 binding of b-catenin to TCF 30 nM
K17 binding of b-catenin to APC 1200 nM
Concentration ratios
APC =Axin =GSK3b ðÞ
APC=Axin=GSK3b ðÞ
2
b   catenin =APC =Axin =GSK3b ðÞ
b   catenin=APC =Axin =GSK3b ðÞ
1
Flux and flux ratio
m11 degradation flux of b-catenin via the proteasome 25 nM/h
m13/m11 0.015
Characteristic times
sK.P phosphorylation/dephosphorylation of APC and axin 2.5 min
sGSK.ass GSK3b association/dissociation 1 min
sax.deg Axin degradation 6 min
The data are grouped into concentrations of pathway components, dissociation constants of protein complexes, concentration ratios, uxes and ux ratios, and characteristic
times of selected processes. Experimental evidence for these data is discussed in the text. From these data, the following rates and rate constants are calculated: m12¼0.42
nM   min
 1 (rate of b-catenin synthesis), m14¼8.2   10
 5   nM min
 1 (rate of axin synthesis), k4¼0.27 min
 1, k5¼0.13 min
 1, k6¼9.1   10
 2 nM
 1   min
 1, k 6¼0.91   nM
 1  
min
 1, k9¼210 min
 1, k10¼210 min
 1, k11¼0.42 min
 1, k13¼2.6   10
 4 min
 1, k15¼0.17   min
 1. See Table S2, found at http://dx.doi.org/10.1371/journal.pbio.0000010.st002,
for more precise numbers used in the calculations.
Bold: Measured values, Italics: Estimated values.
DOI: 10.1371/journal.pbio.0000010.t001
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hyperstimulated state deﬁned as W . 1. In order to calculate
concentrations in the standard stimulated state, additional
input quantities are required. These include the ratio of the
active and inactive forms of Dsh (Dsha/Dshi), the relation
between non-Dsh-mediated and Dsh-mediated release of
GSK3b from the destruction complex (the ﬂux ratio m 6/m3),
and the characteristic time for the Dsh activation/inactivation
cycle (sDsh.act). These values are not at present measurable. The
values for these input quantities are listed in the legend of
Table 2. In a later section, we analyze the effects of changes in
these additional input quantities.
By setting W ¼ 1 and ﬁxing all other parameters, we arrive
at steady-state solutions of the systems equations (see Dataset
S1, Equations. [A-1]–[A-15]), which yield the numerical
variables for the standard stimulated state (listed in the
second column of Table 2). A comparison of this state with
the reference state shows that the concentration of free
nonphosphorylated b-catenin increases by a factor of
approximately 6, from 25 to 153 nM. Upon Wnt stimulation,
the free phosphorylated b-catenin concentration decreases
by 8%, from 1 nM to 0.92 nM. The increase in b-catenin levels
reﬂects the decrease in its degradation caused by the
reduction in the ability of GSK3b to phosphorylate it. The
concentration of the b-catenin/TCF complex increases by a
factor of 1.8. The large increase in b-catenin concentration
shifts the binding equilibrium between APC and b-catenin
and the concentration of free APC falls slightly. Total axin
concentration decreased by a factor of 2.7 upon Wnt
stimulation since addition of Dsh decreases the concentration
of the various axin containing complexes. Remarkably, the
steady-state concentration of free axin is constant during the
transition from W ¼ 0t oW ¼ 1. This is due to the fact that
under steady-state conditions, the rate of axin synthesis
equals its degradation; the rate of synthesis (m14) is a ﬁxed
value and the rate of degradation depends solely on the
concentration of free axin (and independent of other
parameters such as binding constants and strength of the
Wnt signal).
As expected, simulations of increasing Wnt activation (0  
W   1.4) on the steady-state concentrations of b-catenin and
axin reveal a nearly hyperbolic saturation of increasing
concentrations of nonphosphorylated and total b-catenin
with increasing strength of Wnt stimulation. Furthermore,
Wnt stimulation affects the steady-state concentrations of
axin and b-catenin in an opposite direction (see Figure S1,
found at http://dx.doi.org/10.1371/journal.pbio.0000010.
sg001).
b-Catenin Degradation: Comparison of Theory and
Experiment
To test whether the mathematical model represented the
Wnt pathway under a variety of conditions, we ran through a
series of simulations, all of which used the same set of
parameters. From these we calculated simulated timecourses
for b-catenin degradation under a range of different
conditions (increased axin concentration, increased Dsh
a
concentration, inhibition of GSK3b, increased TCF concen-
tration) (Figure 2A). We then tested the results using the
previously described biochemical system (Salic et al. 2000; Lee
et al. 2001), adding puriﬁed proteins or compounds at t ¼ 0
(Figure 2B). Simulations and experimental results are each
shown as plots of total b-catenin concentration versus time.
The agreement between theory and experiment is excellent.
The straight line for t , 0 represents the reference state.
The simulated reference state curve (Figure 2A, curve a) for
b-catenin degradation is calculated for t . 0, at which there is
an absence of protein synthesis for axin (m14 ¼ 0) and b-
catenin (m12 ¼ 0). This reference curve is in close agreement
with our experimental data (Figure 2B, curve a9)w i t h
identical half-lives for b-catenin degradation (theoretical
value of t½ ¼ 60.2 min versus experimental value of t½ ¼ 60
min). We examined a new state, where we have increased the
amount of endogenous axin (0.02 nM) by 0.2 nM. As shown in
Figure 2A, curve b, the additional axin markedly accelerated
b-catenin degradation (t½ ¼ 11.8 min) in agreement with the
experimentally obtained values (Figure 2B, curve b9; t½ ¼ 12
min). Theoretically, the effect of axin on b-catenin degrada-
tion is primarily due to the large concentration difference
between the two scaffold proteins, APC and axin. Owing to
the high concentration of APC, an increase in axin concen-
tration results in a sharp increase in the concentration of the
APC/axin complex, thereby accelerating b-catenin binding to
the destruction complex.
Curve d in Figure 2 shows the effect of inhibiting GSK3b on
b-catenin degradation. This effect is produced in the
simulation by inhibiting GSK3b activity (steps 4 and 9). Only
a small fraction of b-catenin (phosphorylated b-catenin) is
available for degradation after complete inhibition of b-
catenin phosphorylation (step 9), so inhibition is rapid. This
Table 2. Steady-State Concentrations of Pathway Compounds in
the Reference State and in the Standard Stimulated State
Compound Concentration (nM)
W ¼ 0 W ¼ 1
Dshi 100 9.09
Dsha 0 90.9
(APC*/Axin*/GSK3b) 9.66 10
 3 1.46 10
 3
(APC/Axin/GSK3b) 4.83 10
 3 7.29 10
 4
(APC/Axin) 9.66 10
 4 9.75 10
 4
APC 98.0 88.7
(b-catenin/APC) 2.05 11.3
(b-catenin/APC*/Axin*/GSK3b) 2.02 10
 3 1.86 10
 3
(b-catenin*/APC*/Axin*/GSK3b) 2.02 10
 3 1.86 10
 3
b-catenin* 1.00# 0.92
b-catenin 25.1 153
Axin 4.93 10
 4 4.93 10
 4
TCF 8.17 2.46
(b-catenin.TCF) 6.83 12.5
b-catenin
0 35.0# 178
Axin
0 2.00 10
 2# 7.28 10
 3
Calculation of the concentrations is performed by the systems equations (see
Dataset S1) under steady-state conditions. For the reference state (W ¼ 0), the
corresponding parameters given in Table 1 are used. Values marked by ‘‘#’’
represent steady-state concentrations, which also appear in Table 1. The additional
input quantities required for the calculation of the standard stimulated state (W ¼
1) are taken as follows: Dsh a /D s hi¼k1 /k 2¼10, m 6 / m3¼k 6 / (k3 Dsha)¼0.2, and
sDsh.act ¼1 / (k1þk2)¼5 min. This yields the following values for rate constants: k1
¼ 0.18 min
 1, k2 ¼ 1.8   10
 2 min
 1, k3 ¼ 5.0   10
 2 nM
 1   s
 1.
DOI: 10.1371/journal.pbio.0000010.t002
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which degradation is essentially blocked after inhibiting
GSK3b activity by lithium (Figure 2B, curve d9). Curve e in
Figure 2A predicts that b-catenin degradation is strongly
inhibited after the addition of 1 lM TCF. Previously we have
shown that b-catenin is sequestered by TCF, thereby resulting
in a signiﬁcant decrease in free b-catenin (Lee et al. 2001).
The addition of TCF would be expected to decrease the rate
of b-catenin phosphorylation (step 9) and subsequently b-
catenin degradation. This is also seen experimentally (Figure
2B, curve e9).
The immediate inhibition by LiCl is in contrast with the
action of Dsh that inhibits only after a signiﬁcant delay. We
were intrigued by the theoretical biphasic degradation curves
of b-catenin in the presence of Dsha,a sw e l la st h e
experimental support for it (Figure 2A and 2B, curves c and
c9). In both cases, there is an initial rapid decrease in b-
catenin in the ﬁrst 30 min to 1 h, followed by a much slower
decrease. Such a feature should allow us to distinguish
mechanistic details of complex formation. Experimentally,
the biphasic nature of Dsh activity is not due to a delay in Dsh
activation upon its addition to the Xenopus extracts since we
see the same effect with Dsh protein that has been ‘‘activated’’
with extracts prior to its use in our degradation assay. As
shown in Table 1, the characteristic time sK.P of phosphor-
ylation and dephosphorylation of APC and axin in the
destruction complex is relatively slow (2.5 min), and it
therefore takes 5 min for 75% of the complex to be
dephosphorylated. If Dsha acted only on the dephosphory-
lated complex (through step 3) to remove GSK3b and thus
block phosphorylation of the complex, then we would predict
the biphasic kinetics shown in Figure 2A, curve c. These data
suggest that Dsh inhibits the phosphorylation of the scaffold
complex by GSK3b, but does not inhibit the phosphorylation
of b-catenin. When Dsh binds, the complex can go around
many times binding and phosphorylating b-catenin before it
dissociates and is inhibited by Dsh. One hour after the
addition of Dsh, b-catenin degradation is signiﬁcantly
inhibited due to the removal of a signiﬁcant pool of GSK3b
from the degradation complex over time (through the action
of Dsh). As a result, the scaffold protein axin is dephosphory-
lated by the phosphatase (step 5) that remains bound to the
degradation complex. Dephosphorylated axin is rapidly
ubiquitinated and degraded when the b-catenin degradation
normally stops. The small decrease in b-catenin levels in
Figure 2, curve c, after a 1 h incubation with Dsh, is due to
degradation of b-catenin via nonWnt pathway mechanisms
(see Table 1) that we have incorporated into our model.
To test this prediction beyond consistency with exper-
imental data, we performed an experiment in which Dsh was
either preincubated with extract before or added at the same
time as radiolabeled b-catenin (Figure 3). If b-catenin and
Dsh are added at the same time, there is an initial rapid loss
of b-catenin (Figure 3, curve b) followed by pronounced
inhibition of degradation after 1 h. This initial rapid loss is
consistent with Dsh acting on a subpopulation of degradation
complexes (presumably the unphosphorylated forms). Strik-
ingly, preincubation with Dsh prior to the addition of
radiolabeled b-catenin (Figure 3, curve a) results in immedi-
ate action of Dsh. We interpret this result to simply reﬂect the
fact that over time in the preincubated extract Dsh can
remove GSK3b from the degradation complexes, thereby
enhancing the activity of the phosphatase and, as a result,
promoting the degradation of axin and inhibition of b-
catenin degradation. The small decrease in b-catenin levels at
t . 2 h in both curves a and b again suggests the existence of a
slow degradation process mediated by non-Wnt pathway
mechanisms.
Clues to Axin Activity from Its Very Low Cellular
Concentration
In establishing quantities for our model in Table 1, we
found that the axin concentration (20 pM) is much lower than
the concentration of the other major components (b-catenin,
35 nM; APC, 100 nM; Dsh, 100 nM; and GSK3b, 50 nM). This
unusual ﬁnding suggests that the function of the Wnt
signaling system may actually depend on a low axin
Figure 2. Kinetics of b-Catenin Degradation: Simulation and Experimental Results
(A) Simulated timecourses of b-catenin degradation. The straight line for t , 0 corresponds to the reference state of b-catenin using the
parameters given in the legends of Table 1 and 2. In vitro conditions are simulated by switching off synthesis of b-catenin and axin (m12¼0, m14¼
0 for t   0). Curve a: reference case (no addition of further compounds); curve b: addition of 0.2 nM axin; curve c: addition of 1 lM activated Dsh
(deactivation of Dsh was neglected, k2 ¼ 0); curve d: inhibition of GSK3b (simulated by setting k4 ¼ 0, k9 ¼ 0); curve e: addition of 1lM TCF.
Addition of compounds (axin, Dsh, TCF) and inhibition of GSK3b was performed at t ¼ 0.
(B) Experimental timecourse of b-catenin degradation in Xenopus egg extracts in the presence of buffer (curve a9), axin (curve b9: 10 nM), Dsh
(curve c9:1lM), Li
þ (curve d9: 25 mM), or Tcf3 (curve e9:1lM).
DOI: 10.1371/journal.pbio.0000010.g002
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axin, GSK3b, and Dsh on the half-lives of b-catenin are shown
in Figure 4A and 4B, respectively. At zero concentration of
Dsh, doubling the concentration of axin (from the reference
state, indicated as 0, to a state where the concentration has
been increased by 0.02 nM) causes a 50% drop in the half-life
of b-catenin. By contrast, a doubling of the GSK3b concen-
tration only decreases the half-life of b-catenin by 10%. The
small effect of GSK3b is predicted to be due to the fact that
only a limited amount of axin can be recruited to the
degradation complex through binding to additional GSK3b.
On the other hand, increased axin concentrations are
immediately translated into an increased concentration of
the destruction complex, because the concentrations of APC
and GSK3b are high. Changing the concentration of either
GSK3b or of axin should also change the amount of Dsha
required to inhibit b-catenin degradation, but the pathway is
much more sensitive to axin concentration than it is to
GSK3b concentration. In the presence of high concentrations
of axin, the effect of Dsha should be blocked; high concen-
trations of axin will lead to high concentrations of the
phosphorylated destruction complex no matter what level of
Dsha activity is present. High levels of the destruction
complex will require even higher levels of Dsh to overcome
the inhibition. The interaction between Dsha and GSK3b is
similar in principle: Dsh-mediated release of GSK3b (step 3)
from the degradation complex can simply be reversed by
sufﬁciently high concentrations of GSK3b (step 6). In this
case, however, the effect is small. Thus, axin blocks the action
of Dsh so effectively that it renders the Dsh pathway
inoperable.
In Figure 4C and 4D, we studied experimentally the dose-
dependent effects of Dsh, GSK3b, and axin on b-catenin
degradation. These curves represent b-catenin half-lives for
various concentrations of axin (Figure 4C) and GSK3b (Figure
4D) with varying concentrations of Dsh. The results are
qualitatively similar to those predicted by the model. As
expected, b-catenin degradation is inhibited by increasing
Dsh concentration and stimulated by increasing the concen-
tration of either axin or GSK3b. There are, however, two
pronounced differences in the effects of axin and GSK3b on
Dsh inhibition. Whereas axin activates b-catenin degradation
over a wide range of Dsh concentrations (Figure 4C), the
effect of GSK3b becomes signiﬁcant only at high concen-
trations of Dsh (Figure 4D). Furthermore, the inhibitory
effect of Dsh can be almost completely blocked by high
concentrations of axin (10 nM). In contrast, GSK3b (1 lM) can
only partially inhibit the strong inhibitory effect of Dsh on b-
catenin degradation.
Our experimental results, however, show a smaller effect
on the half-life of b-catenin degradation at high concen-
trations of Dsh as GSK3b levels are increased. Also, the
concentrations of added axin in the theoretical curve and the
experimental curves are very different. The quantitative
difference between the model and experimental may simply
reﬂect the fact that the speciﬁc activity of our GSK3b and
axin preparations (puriﬁed from Sf9 cells and bacteria,
respectively) may be low and that a signiﬁcant fraction of
the recombinant proteins may not be active. Alternatively,
the low activity of GSK3b may point to an unidentiﬁed
inhibitory activity present in our Xenopus egg extracts.
Effects of Dynamic Changes in Protein Concentrations
The dependence of ﬂux on the concentration of a pathway
component is a measure of how much the ﬂux is sensitively
Figure 3. Preincubation of Dsh in Xenopus Egg Extracts Abolishes the
Lag in Dsh Activity
Labeled b-catenin was incubated in Xenopus extracts on ice 30 min
prior to (B) or 30 min after (A) the extract had been preincubated
with 1 lM Dsh. No degradation of the labeled b-catenin was detected
while the reactions were on ice. The reactions were started by shifting
to 208C.
DOI: 10.1371/journal.pbio.0000010.g003
Figure 4. The Effect of Dsh versus Axin or GSK3b on the Half-Life of b-
Catenin in Xenopus Extracts
(A and B) Predicted effects of Dsh, axin, and GSK3b on the half-life of
b-catenin degradation. The half-lives are calculated from simulated
degradation curves. Data are plotted as function of added Dsh
(logarithmic scale) for various concentrations of axin (A) and GSK3b
(B).
(C and D) Measured effects of Dsh, axin, and GSK3b on the half-life of
b-catenin degradation. Stimulation of b-catenin degradation by axin
occurs throughout the range of Dsh concentrations tested. (C) Axin
increases the rate of b-catenin degradation even in the absence of
added Dsh. (D) Stimulation of b-catenin degradation by GSK3b is
detected only at high concentrations of Dsh. No effects of GSK3b on
b-catenin degradation can be detected at less than 30 nM added Dsh.
There is a disparity between the concentrations of axin in the
experimental and theoretical curves. We assume that this is most
likely due to the speciﬁc activity of the expressed axin protein.
DOI: 10.1371/journal.pbio.0000010.g004
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the normalized concentration-dependent parameters of the
total ﬂux known as control coefﬁcients have been very useful
in deﬁning the characteristics of pathways (Heinrich and
Rapoport 1974; Fell 1997). Similarly, in the analysis of
bacterial chemotaxis, the response of a behavioral parameter
as a function of changes in speciﬁc kinetic rates has been
termed robustness (Alon et al. 1999). Such terms are rarely
measured in signal transduction.
To determine the effects of changes in the levels of Wnt
pathway components, we analyzed how the ﬂux (b-catenin
degradation) changes with changes in the concentrations of
APC
0, GSK3b
0, Dsh
0, and TCF
0 (see Figure S2, found at http://
dx.doi.org/10.1371/journal.pbio.0000010.sg002).
We chose to focus on the effects of changes in the
concentrations of pathway components in the reference
state, because similar effects were also seen for the stimulated
state. Recently, we investigated a new and important property
of the Wnt pathway, namely that the degradation of axin
(reaction 15) is dependent on APC (unpublished data). The
degradation rate of axin is mathematically expressed in the
following manner:
m15 ¼
k
0
15APC   axin
KM þ APC
ð5Þ
where KM represents a half-saturation constant for the
activating effect of APC.
The theoretical effect of APC on the concentrations of
both b-catenin and axin is shown in Figure 5, where we
considered independently the effect of APC-mediated deg-
radation of axin (‘‘with regulatory loop’’ where Equation [5] is
applied) or the absence of such an effect (where the linear
rate equation m15 ¼ k15 axin is applied). With APC-mediated
axin degradation, b-catenin degradation is affected very little
by changes in the concentration of APC (25% decrease with a
2-fold increase in APC concentration). This resistance to
changes of b-catenin levels upon changes in APC concen-
tration is due to the APC-dependence of axin degradation
(see Figure 1 and Equation [5]). Decreasing the concentration
of APC inhibits the degradation of axin, thereby promoting
the formation of the degradation complex. As shown in
Figure 5, in the absence of the regulatory loop, axin
degradation is APC independent, homeostasis is lost, and b-
catenin levels are greatly upregulated with decreasing APC
concentrations. A comparison of the curves that represent
the dependence and independence of axin degradation on
APC (dashed lines in Figure 5) indicates that the regulatory
loop acts in such a way that the normally inhibitory effect on
b-catenin degradation as a result of lowering the concen-
tration of APC is counteracted by an increase in axin levels.
We have also simulated the effects of changes in the rate of
b-catenin (m12) and axin (m14) synthesis on both b-catenin and
axin levels (see Figure S3, found at http://dx.doi.org/10.1371/
journal.pbio.0000010.sg003). Interestingly, changing the level
of axin or b-catenin affects the concentration of the other
component in different ways. An increase in the synthesis of
axin results in a decrease in b-catenin, whereas increasing b-
catenin synthesis leads to an increase in axin levels. This latter
effect contrasts with effects observed upon changes of other
parameters (see Figure S2) that affect the concentrations of
axin and b-catenin in opposite directions.
Transient Stimulation of the Pathway
Wnt stimulation in vivo is transient, likely due to receptor
inactivation/internalization and/or other downregulatory
processes.
We model transient Wnt stimulation by an exponential
decay:
W ¼f
0 ; for t,t0
e k t t0 ðÞ; for t   t0
ð6Þ
where the reciprocal of k represents the characteristic
lifetime sW of receptor stimulation and t0 denotes the onset
of signaling. The concentration changes of all other pathway
compounds resulting from Wnt stimulation can be calculated
by numerical solution of the system equations (see Dataset
S1), with initial values of the variables corresponding to the
reference state.
Regulating axin turnover is important for Wnt signaling.
Wnt-stimulated axin turnover has been reported in cultured
mammalian cells (Yamamoto et al. 1999) and in Drosophila
(Tolwinski et al. 2003). In a future paper we will show that
axin turnover is affected inversely to b-catenin turnover by
phosphorylation by GSK3b. Here we show theoretically that
this regulated axin turnover sharply affects the dynamics of
the response. Figure 6 shows the time-dependent behavior of
the total concentration of b-catenin and the total concen-
tration of axin upon transient Wnt stimulation. The concen-
tration of b-catenin increases transiently and then returns to
its initial value. In contrast, the concentration of axin is
temporarily downregulated. Further analysis of Figure 6
reveals that the amplitude of the b-catenin signal upon
transient stimulation is signiﬁcantly lower than the steady-
state concentration upon permanent stimulation (W ¼ 1; see
Figure S1). The curves a and a9 in Figure 6 are calculated for
the reference values of the rate of axin synthesis and of the
rate constant of axin degradation, whereas the curves b and
Figure 5. Effect of the Regulatory Loop for Axin Degradation
The case ‘‘with regulatory loop’’ takes into account that axin
degradation is APC-dependent (black curves). Alternatively, the case
without this regulatory loop is considered (red curves). For the
regulatory loop, the rate law (5) is used assuming that in the reference
state the APC activation is half of its maximum (KM ¼ 98.0 nM). The
value of k9 15 was chosen such that in the reference state both cases,
with and without regulatory loop, yield the same degradation rate of
axin (k9 15 ¼ 0.33 min
 1).
DOI: 10.1371/journal.pbio.0000010.g005
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both parameters are increased by a factor of 5 and decreased
by a factor of 5, respectively. Under these conditions, both the
degradation rate and the synthesis rate are altered by the
same factor, thus maintaining essentially identical steady-
state concentrations of axin. As a result, the steady-state
concentrations of axin are the same in the unstimulated
condition (W ¼ 0) and after diminution of the Wnt signal;
however, during active signaling, the differences in the
dynamic nature of signal output at differing rates of axin
turnover are dramatically revealed.
Interestingly, an increase in the turnover rate of axin leads
to higher amplitudes and shorter durations of the b-catenin
signal. This can be explained by the faster degradation of axin
after its Dsh-mediated release from the destruction complex.
Thus, b-catenin degradation is effectively inhibited for a
certain time period due to a reduced availability of the
scaffold axin.
Since the steady-state concentration of free axin remains
unchanged (rate of axin synthesis equals the rate of its
degradation) during the transition from W¼0t oW¼1, a fast
axin turnover favors rapid replenishment of the axin pool
after the decline of the Wnt stimulus and, in this way, fast
recovery of the destruction complex. This explains why the b-
catenin signal is not only ampliﬁed, but becomes more spike-
like. Increasing the turnover rate of axin affects the response
of axin to temporary Wnt stimulation in a similar way as the
response of b-catenin; i.e., the signal is ampliﬁed and
sharpened (Figure 6). Closer inspection of Figure 6 reveals
that the axin response precedes the b-catenin response. For
example, in the reference case, the b-catenin concentration
reaches its maximum at about 260 min (curve a), whereas the
minimum of the axin concentration is reached at 130 min
(curve a9). This effect can be understood by observing that it
is the lowering of the axin concentration that decreases the
concentration of the destruction core complexes; in turn, this
stabilizes b-catenin.
Mechanistic Differences between APC and Axin as
Scaffolds
As the axin concentration is several orders of magnitude
lower than that of the other components in the degradation
pathway (see Table 1), we decided to test the effect of
increasing axin levels (up to, equal to, and greater than the
concentrations of other components in the pathway). To do
this, we had to extend the model to include additional
reactions, marked in blue in Figure 1; these had previously
been neglected due to the very low axin concentrations. High
axin concentrations affect most prominently the formation
of the b-catenin/axin complex. Assuming a realistic value for
the b-catenin–axin dissociation constant (K18 ¼ 1 nM), a
moderate increase in axin concentration should theoretically
accelerate b-catenin degradation, whereas a much higher
concentration should result in inhibition of b-catenin
degradation, due to the formation of partial complexes on
axin. A more extensive analysis of b-catenin half-lives over a
range of axin concentrations shows such a biphasic curve
( F i g u r e7 A ,c u r v eb ) .T h e s ee f f e c t sc a na l s ob es e e n
experimentally in extracts (Figure 7B), where 10 nM axin
accelerates and 300 nM axin inhibits b-catenin degradation.
The t½ decrease for low amounts of added axin can be easily
explained by the fact that greater amounts of APC and
GSK3b can be recruited to form the destruction complex. As
a result, the t½ decreases from 60 min to t½¼3 4 min. The
inhibitory effect of axin becomes apparent only for axin
concentrations approaching that of the other components.
As shown in Figure 7A, the effect of axin binding only to
GSK3b (K19 ¼ 1 nM, K18 ! ‘) only becomes inhibitory at
higher than micromolar concentration (curve c), whereas the
combined effect of binding to both b-catenin and GSK3b (K18
¼ 1 nM, K19 ¼ 1 nM) shows inhibition at less than 500 nM
(curve d). If, however, we model an ordered process of
binding to axin, then abortive inhibitory complexes cannot
form. We show this in Figure 7A. Here there is no separate
binding of axin to b-catenin or GSK3b. In this case, there is
no increase in the t½ at high axin concentrations (Figure 7A,
curve a).
Figure 6. Timecourse of b-Catenin and Axin Concentrations Following a
Transient Wnt Stimulation
Transient activation of the pathway is modeled assuming a Wnt
stimulus that decays exponentially (Equation [6] with sW ¼ 1/k ¼ 20
min) starting at t0 ¼ 0. The straight line for t , 0 corresponds to the
steady state before pathway stimulation. The curves are obtained by
numerical integration of the differential equation system (see Dataset
S1). The various curves for b-catenin and for axin differ in the
turnover rate of axin determined by the parameters m14 and k15
(curves a: reference values of these parameters; curves b: increase by a
factor of 5; curves c: reduction by a factor of 5). All other parameters
are given in the legend of Table 2.
DOI: 10.1371/journal.pbio.0000010.g006
PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 1 | Page 125
Mathematical Modeling of the Wnt PathwayWe also examined theoretically the effects of increasing
APC concentration on the half-life of b-catenin, as shown in
Figure 8. The black curve corresponds to a nonordered
mechanism, such as that found in axin, in which the b-
catenin–APC dissociation constant (reaction 17) is low. The
inhibitory effect of APC at high concentrations is due to its b-
catenin buffering activity. The green curve corresponds to an
ordered mechanism and reﬂects a high b-catenin–APC
dissociation constant (high K17). In this case, increasing
concentrations of APC greater than the reference concen-
trations does not lead to inhibition of b-catenin degradation
even at very high concentrations of APC. In cultured cells,
overexpression of APC stimulates b-catenin degradation
(Munemitsu et al. 1995; Papkoff et al. 1996). Unfortunately,
we are presently unable to express full-length APC in Xenopus
egg extracts to measure the effects of high levels in the extract
system.
b-Catenin can also be degraded by nonaxin-dependent
mechanisms, which include Siah-1 and presenilin-mediated
degradation. Though they are expected to contribute very
little to the total ﬂux through the pathway, the nonaxin-
dependent processes may have very important inﬂuences
under certain conditions. In our Xenopus system, these
alternative pathways do not contribute greatly to the half-
life of b-catenin. Experimentally, we have measured only a
1.5% contribution to total b-catenin degradation such that
the half-life of b-catenin is 45 h when the axin-dependent
processes are inhibited. If in some situations the nonaxin-
dependent degradation contributed 10% to the ﬂux, the half-
life would be 6.3 h (k13 ¼ 1.83   10
 3 min
 1). The alternative
pathways have very little effect on the half-life of b-catenin at
normal and supranormal concentrations of APC. However,
the effect of these alternative pathways becomes much more
prominent when the APC concentration is lowered, a
situation that may be signiﬁcant under pathological con-
ditions. As seen in Figure 9A, when APC levels are at 50% of
their normal concentration, there are dramatic differences in
b-catenin concentration, depending on whether the alter-
native degradation pathway contributes to 1.5% or 10% of
the total b-catenin degradation activity. The importance of
the regulatory loop involving APC-mediated axin degrada-
tion is shown in Figure 9B. In the absence of the regulatory
loop, a signiﬁcant inhibition of APC levels would strongly
inhibit axin degradation, leading to a large increase in b-
catenin levels. The control of b-catenin would be very brittle
in this circumstance. However, by making axin degradation
dependent on APC, a loss of APC would not stabilize axin
levels, and the high axin levels would support continued
degradation of b-catenin. This is the situation labeled ‘‘with
regulatory loop’’ shown in Figure 9B. The control of axin
degradation could be a decisive factor in the response of the
system to genetic or environmental effects on APC.
Control, Modular Composition, and Robustness of the
Wnt Pathway
The model contains many parameters that affect the system
behavior in different ways and to various extents. We can
Figure 7. Effects of Increasing Axin Concentration on b-Catenin
Degradation
(A) Effect of axin concentration on b-catenin half-life. Curve a:
reference case (K18, K19 . 1 nM, ordered mechanism); curve b: K18¼1
nM, K19 . 1 nM; curve c: K18 . 1 nM, K19¼1 nM; curve d: K18¼1 nM.
(B) High concentration of axin inhibits b-catenin degradation in
Xenopus egg extracts. Labeled b-catenin was incubated in Xenopus
extracts in the absence (0 nM) or presence of moderate (10 nM) and
high (300 nM) concentrations of axin. Moderate concentrations of
axin greatly accelerate, whereas high concentrations inhibit b-catenin
degradation.
DOI: 10.1371/journal.pbio.0000010.g007
Figure 8. Effects of APC Concentrations on b-Catenin Degradation
Effect of APC concentration on b-catenin half-life assuming an
ordered (curve a) or nonordered mechanism (curve b: K17 ¼ 1,200
nM), respectively.
DOI: 10.1371/journal.pbio.0000010.g008
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whose perturbation the system is most sensitive or most
robust against. We focus on the concentrations of b-catenin
and axin and calculate the responses in the total concen-
trations of these two compounds upon changes in the rates of
the individual processes. For quantifying the effects of the
rate constants kþi and k i, we use control coefﬁcients for the
total concentration of b-catenin
C
bcat
6i ¼
k6i
b   catenin
@ b   catenin ðÞ
@k6i
ð7Þ
and corresponding deﬁnitions for the control coefﬁcients
C
axin
6i for the total axin concentration. These coefﬁcients,
originally proposed for quantifying control in metabolic
networks (for reviews, see Heinrich and Schuster 1996; Fell
1997), describe the relative changes of the concentrations of
the given compounds to relative changes of the rate
constants. The control coefﬁcients for the reference state
are listed in Table 3. It should be remembered that the
following discussion refers to small perturbations of the
reference state.
For the reference state, there are six steps exerting strong
negative control on the total b-catenin concentration (C
bcat
i ﬃ
 1). This group includes the reactions participating in
assembling the destruction complex APC*/axin*/GSK3b.
The corresponding parameters involve the rate constants k7
for the binding of axin to APC, k6 for the association of
GSK3b to the APC/axin complex, and k4 for the phosphos-
phorylation of axin and APC in the destruction complex.
Similar strong negative control is exerted by b-catenin
binding to the phosphorylated destruction complex (rate
constant: k8), the phosphorylation of b-catenin in the
destruction complex (rate constant: k9), and the synthesis of
axin (m14).
Six other reactions exert strong positive control in the
reference state on the total concentration of b-catenin
(concentration (C
bcat
i ﬃ 1). To this group belong the reactions
participating in the disassembly of the destruction complex
APC*/axin*/GSK3b, which are described by the rate constants
k 7 for the dissociation of the APC/axin complex, k 6 for the
dissociation of GSK3b from the destruction complex, and k5
for the dephosphorylation of the APC and axin in the
destruction complex. Other steps with a high positive control
are the dissociation of b-catenin from the destruction
complex (rate constant: k 8), axin degradation (rate constant:
k15), and b-catenin synthesis (m12).
There are many reactions exerting almost no control on b-
catenin levels in the reference state. This group includes
binding of b-catenin to TCF and APC (k16 and k17), and the
corresponding dissociation processes (k 16 and k 17; again
only valid for small perturbations). Interestingly, the effects
of the two b-catenin degradation processes (rate constants:
k11 and k13) are also small. Calculation of control coefﬁcients
for the standard stimulated state reveals that some steps that
exert no control in the reference state become important.
These are the activation and inactivation of Dsh (rate
constants: k1 and k2) and, more pronounced, the Dsh-
mediated release of GSK3b from the destruction complex
(k3). For all other processes, the signs of the control
coefﬁcients for b-catenin and axin do not change at the
transition from the reference state to the standard stimulated
state. The effects of parameter changes on axin are generally
opposite to those on b-catenin; i.e., processes with a positive
control coefﬁcient for b-catenin have negative control
coefﬁcients for axin and vice versa. A signiﬁcant exception
is the synthesis of b-catenin, which exerts a positive control
not only on b-catenin but also on axin, as expected from the
results obtained in the last section.
Closer inspection of Table 3 reveals that the values of the
control coefﬁcients for the rate constants sum up to zero.
Figure 9. Effects of the Alternative b-Catenin Degradation Pathway and
of Axin Degradation at Low Concentrations of APC
(A) The alternative b-catenin degradation pathway (axin indepen-
dent) can have profound effects on b-catenin levels at low APC
concentrations. Variations of b-catenin and axin resulting from
changes in APC concentration were calculated from the standard
stimulated state. Relative variations were plotted since variation in
the share of alternative degradation (1%, 5%, and 10%) results in
changes of the standard stimulated state (all parameters are constant).
b-Catenin and axin levels for varying contributions of the alternative
degradation pathway are as follows: 1.5%, b-catenin 178 nM, axin
0.00728 nM; 5%, b-catenin 151 nM, axin 0.00679 nM; 10%, b-catenin
125 nM, axin 0.00629 nM.
(B) Inhibition of axin degradation reduces b-catenin concentration
after loss of APC. Plotted is the concentration of a potential
proteasome inhibitor I (scaled to its inhibition constant, KI) necessary
to reduce b-catenin concentration to its original level, depending on
the concentration of APC.
DOI: 10.1371/journal.pbio.0000010.g009
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tration control (Heinrich and Rapoport 1974) and is valid for
all reaction networks at steady state. This result ﬁnds its
explanation in the invariance of the steady-state concen-
trations against simultaneous change of all rate constants by
the same factor. Interestingly, in the present case there are
subgroups of processes whose control coefﬁcients separately
sum up to zero, indicating a modular structure of the
pathway. In Table 3, the control coefﬁcients of the different
modules are separated by horizontal lines. The main four
subgroups are the Dsh module (not shown in Table 3), the
kinase/phosphatase module, the b-catenin module, and the
axin module. A subgroup is deﬁned by a set of reactions
where the control coefﬁcients of the binding reactions are
opposite to those of the corresponding dissociation reactions
(Cþi ¼  C i for i ¼ 6, 7, 8, 16, 17).
For those more familiar with genetic manipulation, it is
more common to vary the concentrations of individual
components rather than vary the rate constant of a reaction.
Table 4 shows the control coefﬁcients for b-catenin and axin
calculated for changes in the total concentrations of pathway
components instead of the rate constants. Using the values of
Table 4, the potential tumor-supressing effects (of APC,
GSK3b, and axin) and potential oncogenic effects (of PP2A,
TCF, Dsh, b-catenin) can be explained and quantiﬁed. It may
be worth mentioning that there is no summation theorem for
the control coefﬁcients when calculated by changing total
concentrations instead of rate constants. For practical
reasons, it may be easier to discuss the coefﬁcients with
respect to concentration changes (Table 4); for theoretical
reasons, changing rate constants are simpler to handle. We
think that eventually it will also be clearest to speak about
oncogenic reactions instead of oncogenic genes, especially if
we are thinking of oncogenesis in response to pharmacologic
or environmental perturbations. Genetic defects then can be
considered in terms of changes in activity, transcription,
translation, or proteolysis.
Clearly, the robustness of a variable towards parameter
changes is higher the lower the corresponding concentration
control coefﬁcient. To arrive at an estimation of the overall
effects of parameter perturbations on the system as a whole,
we consider ﬁrst the standard deviation r of the control
coefﬁcients from their mean value. According to the
summation theorem, the mean value of all control coefﬁ-
cients for a given variable is zero. Thus, we get for the
standard deviation for the control coefﬁcients of b-catenin:
rbcat ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n
X
j
C
bcat
j
   2
s
ð8Þ
where the summation is performed over all reactions,
including forward and backward steps of fast equilibria. High
values of r indicate that the given variable is on average very
sensitive towards changes of rate constants. We propose to
introduce a measure for the robustness q of a variable
towards changes of all parameters in the following way:
q ¼
1
1 þ r
: ð9Þ
As r may vary between zero and inﬁnity, the range of q is
conﬁned to the interval 1  q   0. High values of q resulting
from low r values for the control coefﬁcients indicate that
the variable is robust against parameter perturbations. The
standard deviations r of the control coefﬁcients and the q
values for b-catenin and axin are presented in the last two
rows of Table 3. Because many control coefﬁcients are close
to zero and the absolute values of the others hardly exceed
unity, the r values for b-catenin as well as for axin are rather
small. Since all values for r are lower than unity, a 1% change
in a rate constant leads, on average, to a response of ,1% in
the overall level of b-catenin. The total concentration of axin
is more robust against parameter perturbations than the total
concentration of b-catenin, particularly in the standard
stimulated state. A transition from the reference to the
standard stimulated state results in a lower robustness for b-
catenin and a higher robustness for axin.
Discussion
Theory and quantitation are mutually dependent activities.
It would seem unlikely that one would go to the trouble to
measure detailed kinetic quantities without a speciﬁc model
to test, and it is equally unlikely that realistic models can be
constructed without the constraints of quantitative exper-
Table 3. Control Coefficients for the Total Concentrations of b-
Catenin and Axin and Parameters Quantifying the Sensitivity and
the Robustness of the Wnt/b-Catenin Pathway
Parameter of
step j
C
bcat
j C
axin
j
Kinase/ k4  0.89 0.50
phosphatase module k5 0.89  0.50
b-catenin module k9  0.89  0.08
k10  (10
 5)  0.10
k11  0.03 0
m12 0.93 0.19
k13  0.01  0.01
Axin module m14  0.89 0.82
k15 0.89  0.82
Binding, dissociation k6, k 6 60.89 60.74
k7, k 7 60.89 60.79
k8, k 8 60.89 60.02
k16, k 16 60.11 0
k17, k 17 60.08 60.02
r 0.66 0.44
q 0.60 0.70
The control coefcients (Equation 7) were obtained by numerical determination of
the response to a change of the rate constants of all steps by 1%. Using relative
changes of rate constants less than 1% does not lead to a signicant improvement
of the precision of the C values. Coefcients are given for the reference state.
Horizontal lines separate the coefcients for distinct modules of the pathway. The
last block contains the coefcients for parameters that enter the systems equations
as binding rate constants kþj and dissociation rate constants k j via dissociation
constants Kj ¼ k j /k þj. The upper signs of these coefcients refer to changes in kþj
and the lower sign to changes in k j. The sum of the control coefcients in each
column is zero. Additional summation rules hold true for the rate constants within
each module as well as for the two rate constants of each binding equilibrium. The
standard deviation r of the concentration control coefcients and the robustness q
for b-catenin and axin are calculated by applying Equations (8) and (9).
DOI: 10.1371/journal.pbio.0000010.t003
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part of the Wnt pathway in Xenopus egg extracts was to
acquire the kind of detailed kinetic data required to build a
realistic model. There are several unusual advantages to the
extract system that contributed to this effort. The Xenopus egg
extract is essentially neat cytoplasm; it reproduces the in vivo
rate of b-catenin degradation and responds to known
regulators as expected from in vivo experiments. Kinetic
experiments with high time resolution are possible in this
system, since a well-stirred extract is presumably synchronous
in ways in which collections of cells may not be. In extracts it
is possible to precisely set the level of components by
depletion or addition. The direct output of the canonical
Wnt pathway is an easily measured cytoplasmic event, the
degradation of b-catenin. Thus, in this unusual system it is
possible to acquire quantitative information about signaling
pathways, not achievable in vivo. At the same time, these
extracts have limitations. We have not considered the
receptor events, and it is likely that reactions at the plasma
membrane contribute to dynamic features. Also, our analysis
is incomplete, as there are other components of Wnt
signaling, such as casein kinase Id, casein kinase Ie, and
PAR1, as well as cross-talk from other pathways, that
inﬂuence the behavior of the system. We have also over-
simpliﬁed the multiple phosphorylation steps. We have
assumed a simple interconversion of the phosphorylated
and unphosphorylated complex of axin, APC, and GSK3b,
whereas in reality multiple phosphorylation states exist
within the complex; the states may be random or sequential.
We simply do not have the information to provide a much
more speciﬁc model of phosphorylation interconversions at
this time, although the model could easily be extended.
Finally, there is the question of what Wnt process we are
studying. We are looking at events in the cytoplasm of
unfertilized eggs. Though endowed with all of the core
components of the Wnt pathway, the egg is, as far as we know,
transcriptionally silent and not involved in Wnt signaling,
though this system is active very soon in embryogenesis. Thus,
there is no biological in vivo behavior with which to compare
the in vitro behavior. Nevertheless, the basic core circuitry is
intact and is presumably prepared for the early Wnt events in
the embryo. All the properties of the egg extract system are
very similar to that circuitry in vertebrate somatic cells.
To build a mathematical description of the Wnt signaling
system, we started with the basic circuitry discerned from
previous studies in Xenopus embryos and mammalian cells,
whose similarity to the in vitro system we had already
conﬁrmed. We derived a system of differential equations that
described the time-dependent variations of the system
variables, i.e., the concentrations of the pathway components
and their complexes. Parameters of the model are binding
constants of proteins, rate constants of phosphorylations and
dephosphorylations, rate constants of protein degradation,
and rates of protein synthesis. Model reduction was achieved
by considering conservation relations and by applying rapid
equilibrium approximations for selected binding processes.
Despite these simpliﬁcations, the model consists of a non-
linear system of differential equations whose solution
requires the use of computers. Not all of these parameters
were accessible to measurement. To circumvent this problem,
we used as primary inputs not only kinetic parameters
characterizing individual steps, but quantities that are more
easily accessible from experiment, such as the overall ﬂux of
b-catenin degradation. This allowed us to derive rate
constants as well as protein concentrations in a reference
state, where there was no Wnt signal. This state serves as a
starting point for predicting the system behavior during Wnt
signaling as well as after experimental perturbations.
The basic model reproduced quantitatively the behavior of
the reference state, including perturbations of this state
achieved by varying the concentration of axin, GSK3b, and
TCF. It also reproduced extensions of this to the signaling
state. A wide variety of different sets of experimental data
could be simulated by the same model, employing the same
sets of kinetic parameters. We approached this process
iteratively. For example, the early model did not include
nonaxin-dependent degradation of b-catenin, but inclusion
of this process improved the ﬁt to the experimental data.
More signiﬁcantly, addition of this process had interesting
biological implications, which we discuss.
In many ways, one of the most peculiar ﬁndings was the
very low concentration of axin in the Xenopus extracts. Axin
levels in other organisms may similarly be very low: Drosophila
axin can be detected by Western blotting only following its
immunoprecipitation (Willert et al. 1999). Although our
theoretical and experimental studies have shown that axin
is inhibitory at high concentrations, both indicate that axin is
not present at the optimal concentration for the highest rate
of b-catenin degradation. Therefore, axin levels are not set
for optimality of b-catenin degradation, but are presumably
optimized for some other purpose. Theoretically, axin levels
must be held below the very sharp threshold of Dsh
inhibition. Experimentally, these thresholds, which blunt
Wnt signaling, are observed but are not as sharp as expected,
and this may indicate some other compensatory effects.
These thresholds would limit axin concentration to well
below 1 nM if activated Dsh were constrained to concen-
trations of below 1 lM. Under these circumstances, we can
expect that axin would never be found at concentrations
approaching those of other Wnt pathway components (50–
100 nM).
Table 4. Concentration Control Coefficients for the Total
Concentrations of b-Catenin and Axin Relative to Changes in the
Concentrations of Pathway Components
W ¼ 0 W ¼ 1
C
bcat
j C
axin
j C
bcat
j C
axin
j
APC  0.83 0.79  0.87 0.52
GSK3b  0.89 0.74  0.94 0.40
PP2A 0.89  0.50 0.94  0.30
TCF 0.20 0 0.07 0
Dsh 0 0 0.78  0.33
b-catenin 1.00 0.20 1.00 0.44
Axin  1.08 1.00  1.59 1.00
The control coefcients were obtained by numerical determination of the response
to a change of total concentrations by 1%. Coefcients are given for the reference
state and for the standard stimulated state.
DOI: 10.1371/journal.pbio.0000010.t004
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nents (such as GSK3b, Dsh, and APC) has another design
feature potentially very general and important for the
modularity of metazoan signaling pathways. Axin is a critical
node point for controlling b-catenin levels, but it also
interacts with components shared with several other impor-
tant pathways. The interaction of these components with axin
ﬂuctuates due to Wnt signals (reﬂecting changes in binding as
well as changes in axin levels), yet because the concentration
of axin is so low, there will be no appreciable change in the
overall levels of GSK3b, Dsh, or APC (all these components
important in other pathways would otherwise be driven to
ﬂuctuate). The very low axin concentration thus isolates the
Wnt pathway from perturbing other systems, a simple
mechanism to achieve modularity. Other scaffold proteins
may serve similar functions in other pathways. These insights
follow from a very simple measurement of axin concentration
and suggest the utility of measuring the levels of signaling
pathway components in different cell types and circum-
stances. Since quantitative and kinetic features may be
important in deﬁning modules, it suggests that qualitative
circuit diagrams of signal transduction may overlook very
important design features. Modularity within the Wnt path-
way can be deﬁned by an extension of the summation
theorem of Heinrich and Rapoport (1974), which argues that
the steady state of an entire pathway would have control
coefﬁcients that added to zero. When the Wnt pathway is
broken down to several subpathways, we ﬁnd that within
these subpathways the control coefﬁcients would sum to zero
at steady state. While some of this subdivision is obvious (i.e.,
the kinase phosphatase module involving the phosporylation
of APC and axin complexed to GSK3b), in other cases, such as
the b-catenin module, it is much less obvious. Here the
reactions include the phosphorylation of b-catenin in the
APC/axin/GSK3b complex, the release and degradation of b-
catenin, and the synthesis and nonaxin-dependent degrada-
tion of b-catenin. Balanced perturbation of these subpath-
ways as a whole will not affect the overall ﬂux of b-catenin
degradation. It is not clear whether this concept of
modularity might be extended usefully in two other direc-
tions: modularity in systems not at steady state, i.e., with
transients, and estimates of linkage between pathways by
some deﬁnition of nonzero summations expressing the
degree of independence or modularity.
In addition to work by Kholodenko et al. (1997), this paper
marks one of the ﬁrst extensions of metabolic control theory
to signal transduction. Metabolism and signal transduction
seem very different, the former involving the transfer of mass
and the latter the transfer of information. In addition,
metabolic pathways generally involve dedicated components
and the speciﬁcity of interaction of substrates and enzymes is
very high. Signaling pathways share many components;
interactions are often weak. Metabolism, which has had a
long history of quantitative study, was a natural ﬁeld for the
development of control theory, and this theory has been
successful in converting the speciﬁc information about the
behavior of enzymes in a pathway to the overall behavior of
metabolic circuits. Control coefﬁcients are useful measures of
the impact of a process or quantity on another. In its
application to metabolism, it allowed us to dispose of
erroneous concepts, such as the notion of a rate-determining
step. In signal transduction, control coefﬁcients might play a
similar role. Here they can be used to indicate quantitively
the effects of a particular reaction on some other property,
such as ﬂux through the pathway or concentration of another
component. By this deﬁnition, certain rate constants, such as
the phosphorylation and dephosphorylation of APC and axin,
have a major inﬂuence on the levels of b-catenin, while
others, such as the degradation rate of phosphorylated b-
catenin, have little effect. The sign and magnitude of these
control coefﬁcients give some indication what gene products
could be oncogenes or tumor suppressors. As shown in Table
4, by this criterion APC, GSK3b, and axin are potent tumor
suppressors, whereas b-catenin is an oncogene. Dsh would be
expected to exert only moderate oncogenic effects. Clearly
the effects of certain gene products are dependent on
context, including their rate of synthesis and steady-state
concentration. As our understanding of pathways improve,
the effect of mutation or pharmacologic inhibition could be
estimated quantitatively using control coefﬁcients. The
differences between cell types and organisms could be
exploited to better predict mutagenic and pharmacologic
impact on signal propagation.
Despite considerable progress in identifying components
of the Wnt pathway, many important mechanistic details are
still lacking. In this analysis we have shown that Dsh seems to
act to prevent the phosphorylation of the axin/APC complex,
not the phosphorylation of b-catenin. Dsh (complexed to
GBP) does not seem to be a general GSK3b inhibitor, like Li
þ,
but rather is focused on the two scaffolding proteins. This was
apparent from the biphasic nature of both the theoretical
and experimental curves, which suggested that Dsh inhibited
the rephosphorylation of axin/APC, but still allowed many
cycles of b-catenin phosphorylation, ubiquitination, and
degradation. This mechanism was further proven by a
timing-of-addition experiment. It needs to be further
conﬁrmed and extended by looking speciﬁcally at individual
phosphorylation sites on all the components of the complex.
Another insight into the mechanisms of complex formation
and control of b-catenin degradation concerns the inhibition
of b-catenin degradation at concentrations of axin approach-
ing those of other components. This suggests that axin binds
APC, GSK3b, and b-catenin in random order. As discussed
above, the axin concentration is limited by other factors;
owing to the low concentration of axin, random binding is
not likely ever to be a problem. The situation for APC seems
very different. The concentration of APC is comparable to
that of the other components. Overexpression studies show
no inhibitory effects. These theoretical and experimental
observations suggest that APC as a scaffold must be very
different from axin as a scaffold. Most likely, APC binds
components in an ordered manner.
Metabolic pathways are understandable in terms of the
familiar logic of chemical synthesis; signal transduction
pathways, by contrast, often do not seem to conform to
simple design principles. It is not clear at all whether
signaling pathways have been optimized for a speciﬁc
function or instead whether they are remnants of some early
and rather arbitrary evolutionary experiment, now embed-
ded in other processes that are difﬁcult to change. Systems
analysis, along with experiment, offers some hope of
uncovering latent principles of design. For example, the
modeling of the Wnt pathway gave a theoretical insight into
the function of axin degradation in Wnt signaling. The
PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 1 | Page 130
Mathematical Modeling of the Wnt Pathwaydegree of axin instability dramatically affects the amplitude
and duration of the b-catenin response to a transient Wnt
signal. If axin turnover were designed to be slow, then b-
catenin would rise slowly to a low amplitude and persist for
many hours. In a system where axin turnover was more rapid,
the amplitude could increase several-fold and would persist a
shorter time. The duration and amplitude of the response are
likely to be important factors in developmental systems,
which may respond differently to different amplitudes and
durations of a signal. In addition, some developmental
processes occur with such rapidity that the same signal would
be interpreted differently at different times, hence the need
to quickly terminate a signal. The very different effects of
transient and persistent signals in the same pathway have
been studied in PC12 cells in the MAP kinase pathway
activated by EGF or NGF (Marshall 1995). Finally, APC-
dependent axin degradation stabilizes the Wnt pathway to
variations in the APC concentration. Viewed from this
perspective, the regulatory loop involving APC and axin
degradation is an important design feature of the Wnt
pathway.
Robustness has also been considered an important design
principle for signaling processes (Alon et al. 1999), and
control coefﬁcients can be a good measure of this robustness.
We present here a general measure of robustness of the entire
pathway, using a measure that sums the variation in every
individual reaction. Though it is generally thought that
‘‘robust’’ is good, the complement of robust is adaptability,
and it may be that some aspects of a signaling pathway are
designed to be responsive to changes in some parameters so
that the same pathway can be used differently in different
circumstances by altering key parameters. Since quantitative
measures of the concentration or posttranslational modiﬁ-
cation of signaling proteins are rare in the literature, we have
very little information on whether the organism varies
certain key components to achieve different behavior of the
signaling systems.
Another aspect of robustness is susceptibility to mutation
or pharmacologic or environmental perturbation. The
unexpected minimal phenotypes observed in numerous
mouse knockout experiments have underscored our igno-
rance of the adaptable responses of organisms and in
particular the adaptable nature of signaling pathways. One
unexpected theoretical observation in this paper was the
potential importance of the nonaxin-dependent degradation
for b-catenin, under conditions where the APC levels are
reduced. In our model, the nonaxin-dependent degradation
contributed only a few percent to the overall ﬂux of b-catenin
degradation. Yet if the APC levels fall only 50%, the exact
level of the alternative pathway made a large difference in the
steady-state level of b-catenin. If the activity of the alternative
pathways varied in different tissues, then this simple but
largely silent effect could explain the tissue speciﬁcity of APC
mutations. Similarly, variations in the alternative pathway
might also explain some aspect of individual risk to loss of a
single copy of the APC gene.
An experiment can better be judged by how many
questions it raises than by how many it answers. The same
may be said about theoretical analysis. Such analysis is always
a work in progress, in that the experimental basis is
continually changing to some degree. Some of the exper-
imental changes, though signiﬁcant mechanistically, may have
little effect on the model and its interpretation. Some may
require major revision. In the case of the Wnt pathway, the
theoretical analysis and modeling have already raised several
interesting questions of biological importance. They have
already stimulated further experimentation. More than any-
thing, the modeling has increased the urgency for obtaining
accurate quantitative information about both steady-state
and transient processes in Wnt signaling and for obtaining
information about the differences in parameters in different
tissues and in different organisms.
Materials and Methods
Egg extracts and degradation assays. Xenopus egg extracts were
prepared as described previously (Salic et al. 2000). Extracts were
used either used immediately or stored at –808C after being snap-
frozen in liquid nitrogen. b-Catenin degradation assays were
performed as described before (Salic et al. 2000).
Measurement of b-catenin synthesis. Freshly prepared Xenopus egg
extracts were either supplemented with 25 mM LiCl in Xenopus buffer
(XB) or XB and an aliquot were withdrawn for b-catenin degradation
assays. The free methionine pool in Xenopus embryos is approximately
90 lM, and based on this number, [
35S]methionine was added to the
extract to a give a ﬁnal activity of 1,000 counts per picomole
methionine. Extracts were incubated at 208C, and aliquots were
withdrawn at the indicated times for SDS-PAGE, trichloroacetic acid
(TCA) precipitation, and b-catenin pull-downs. To assay protein
synthesis in the extract, total methionine incorporation was
measured by TCA precipitation. In brief, Xenopus extracts (2 ll),
metabolically labeled with [
35S]methionine as above, were diluted to
100 ll with PBS and supplemented with 2 ll of 2% deoxycholate and
TCA to 5%. The reaction was pelleted at 20,0003g for 10 min at 48C.
After washing with ice-cold acetone and air drying, the radioactivity
of the pellet was measured in a scintillation counter.
To isolate metabolically labeled b-catenin from Xenopus extracts,
we used His-tagged APCm3 cross-linked to Ultralink beads (Pierce,
Woburn, Massachusetts, United States). Since phosphorylated APC
has a much higher afﬁnity for b-catenin, APCm3 beads were ﬁrst
phosphorylated with 300 nM His-tagged GSK3b in 25 mM HEPES (pH
7.7), 1 mM EDTA, 300 mM NaCl, 10 mM MgCl2, 1 mM DTT, and 1 mM
ATP for 1 h at room temperature with shaking. The beads were
washed three times with 25 mM HEPES (pH 7.7), 1 mM EDTA, 300
mM NaCl, 1% Tween, and 1 mM DTT and were then used to pull
down b-catenin. Extracts (50 ll) labeled with [
35S]methionine (see
above) were diluted 53 with XB containing 1% Tween and protease
inhibitors. The diluted extracts were incubated with phosphorylated
APCm3 beads (20 ll) at 48C for 2 h. The beads were washed and
bound protein was eluted by boiling in SDS-PAGE loading buffer.
Labeled b-catenin was detected following SDS-PAGE and auto-
radiography.
Measuring dissociation rates of phosphorylated/nonphosphory-
lated b-catenin from axin. Radiolabeled b-catenin (5 ll) was
phosphorylated using 300 nM His-tagged GSK3b and 100 nM
maltose-binding protein (MBP)–axin in 20 ll of XB containing 10
mM ATP, 20 mM MgSO4, and 50 mM NaCl. For the nonphorphory-
lated control, b-catenin was incubated as above, except that 50 mM
LiCl was used instead of NaCl to inhibit GSK3b. The kinase reactions
were incubated in a shaker for 30 min at 208C and then added to 50 ll
of MBP–axin, bound to amylose beads (1 mg of protein per milliliter
of beads), and brought up to 250 ll with XB containing 50 mM LiCl.
After phorsphorylated and nonphosphorylated b-catenin, respec-
tively, bound to axin beads, the beads were washed three times with
500 ll of XB containing 50 mM LiCl. Dissociation of the bound b-
catenin was initiated by adding 1 lM unlabeled recombinant b-
catenin (His-tagged, from Sf9 cells) and incubated at 208C in a shaker.
At the appropriate times, 5 ll aliquots of beads were quickly
removed, ﬁltered through Wizard minicolumns (Promega, Madison,
Wisconsin, United States), and washed with ice-cold XB (3 ml).
Proteins bound to beads were eluted from the minicolumns with 20 ll
of hot sample buffer, followed by SDS-PAGE and autoradiography.
Recombinant proteins. The expression and puriﬁcation of all
recombinant proteins have been previously described (Salic et al.
2000). Dsh was expressed as an MBP fusion in bacteria. His-tagged
GSK3b, His-tagged Tcf3, His-tagged APCm3, and MBP–axin were
expressed in Sf9 cells.
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Dataset S1. The Roles of APC and Axin Derived from Experimental
and Theoretical Analysis of the Wnt Pathway
View online at http://dx.doi.org/10.1371/journal.pbio.0000010.sd001
(406 KB DOC).
Figure S1. Effect of Wnt Stimulation on the Concentrations of b-
Catenin and Axin
The curves represent steady-state concentrations of b-catenin (solid
lines) and axin (broken lines) as functions of the strength W of Wnt
stimulation. Curve a: free unphosphorylated b-catenin; curve b: free
phosphorylated b-catenin; curve c: total b-catenin; curve d: total axin.
All concentrations are scaled with respect to their values in the
reference state. It is worth mentioning that in the model ‘‘without
regulatory loop,’’ the steady-state concentration of free axin is
determined by the condition X12 ¼ m14/k15, and is, therefore,
independent of Wnt stimulation. View online at http://dx.doi.org/
10.1371/journal.pbio.0000010.sg001 (3,887 KB DOC).
Figure S2. Effects of the Amounts of Pathway Components on the
Concentrations of b-Catenin and Axin
This ﬁgure gives additional information with respect to the effects of
Dsh, TCF, and GSK3b on the steady-state concentrations of total b-
catenin (solid lines) and total axin (dashed lines) for the case of
permanent Wnt-stimulation, W ¼ 1. All concentrations and synthesis
rates are scaled with respect to their values in the stimulated
stationary state. View online at http://dx.doi.org/10.1371/journal.
pbio.0000010.sg002 (4,042 KB DOC).
Figure S3. Effects of Synthesis Rates on the Concentrations of b-
catenin and Axin
The curves represent steady-state values of total concentrations of b-
catenin (solid lines) and axin (dashed lines), depending on the rates of
synthesis of b-catenin and axin. All concentrations and synthesis rates
are scaled with respect to their values in the stimulated stationary
state. View online at http://dx.doi.org/10.1371/journal.pbio.
0000010.sg003 (4,061 KB DOC).
Table S1. Mathematical Notation for Model Variables as Subdivided
into Independent and Dependent Variables
View online at http://dx.doi.org/10.1371/journal.pbio.0000010.st001
(47 KB DOC).
Table S2. Complete List of Model Parameters of the Wnt Signal
Transduction Model
The rate constants marked with ‘‘#’’ play a role only in stimulated
states where W 6¼ 0. Note that some of the numerical values are given
in a higher precision compared to Table 1. View online at http://
dx.doi.org/10.1371/journal.pbio.0000010.st002 (112 KB DOC).
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